256 Steroid receptors and response to medroxyprogesterone treatment in metastatic carcinoma of the breast
✍ Scribed by C.T. de Oliveira; A.J. Pinto; J.C.S. Góes; M.M. Brentani
- Book ID
- 116003708
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 119 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0022-4731
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Estrogen receptors in breast tumors were assayed in 55 premenopausal women undergoing bilateral oophorectomy and in 120 postmenopausal women undergoing bilateral adrenalectomy for treatment of metastatic breast cancer. The data show that 20 (60%) of the 32 patients with estrogen receptor-positive (E
In 47 postmenopausal women with evaluable breast cancer, oral medroxyprogesterone acetate (MPA) was given at a daily dose level of 400 mg. Patients with negative estrogen receptors, poor performance status , or nonresponse to previous endocrine therapy were excluded from this study. There were 25 (